The Cervix Uteri Cancer Screening Coverage in the UK has shown a consistent decline from 78.34 units in 2013 to 73.07 units in 2023. Year-on-year, the coverage decreased by 2.66% from 2022 to 2023, and an average of 0.56% annually over the last 5 years (CAGR). Forecasted data indicates a continuation of this downward trend, with coverage expected to reduce to 71.17 units by 2028, representing a 2.06% total decrease over 5 years and an annual average decline of 0.42% (CAGR).
Future trends to watch for include:
- The impact of new healthcare policies and preventive medicine programs aimed at increasing screening participation.
- Technological advancements that could make screening more accessible and less invasive, potentially boosting coverage rates.
- Public awareness campaigns and educational efforts to emphasize the importance of regular screening.
